Cargando…

Optimal management of thymic malignancies: current perspectives

Thymic epithelial tumors (TETs) belong to orphan oncology. The incidence of TETs is about 1.3–3.2 cases per million worldwide. Following pathology, evolution and prognosis are variable. The World Health Organization classification distinguishes thymomas and thymic carcinomas. TETs are composed of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drevet, Gabrielle, Collaud, Stéphane, Tronc, François, Girard, Nicolas, Maury, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660626/ https://www.ncbi.nlm.nih.gov/pubmed/31413632 http://dx.doi.org/10.2147/CMAR.S171683

Ejemplares similares

Technique of pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural effusion
por: Drevet, Gabrielle, et al.
Publicado: (2020)

Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas
por: Maury, Jean-Michel, et al.
Publicado: (2019)

Epicardial carvernous hemangioma: The diagnostic challenge of a middle mediastinal mass
por: Drevet, Gabrielle, et al.
Publicado: (2021)

Air leaks: leave well enough alone
por: Drevet, Gabrielle, et al.
Publicado: (2022)

Futile lobectomies following video-thoracoscopic exploration for indeterminate pulmonary nodules: a retrospective study
por: Drevet, Gabrielle, et al.
Publicado: (2022)

Evolution of the Surgical Management of Lung Cancer Invading the Spine: A Single Center Experience
por: Drevet, Gabrielle, et al.
Publicado: (2022)

Subtotal Pleurectomy with Intrathoracic Chemo Hyperthermia (HITHOC) for IVa Thymomas: De Novo Versus Recurrent Pleural Disease
por: Chappuy, Benjamin, et al.
Publicado: (2022)

When to proceed to surgical rib fixation?—A single-institution clinical experience
por: Belaroussi, Yaniss, et al.
Publicado: (2023)

Treatment options for stage IVA thymic malignancies
por: Girard, Nicolas
Publicado: (2019)

Hamartochondroma Pleural Lesion Mimicking Liposarcoma: A Case Report
por: Drevet, Gabrielle, et al.
Publicado: (2022)

Thymic malignancies: next-generation sequencing as a tool to select patients for targeted therapies and immunotherapies?
por: Girard, Nicolas
Publicado: (2019)

Immune checkpoints in thymic epithelial tumors: challenges and opportunities
por: Girard, Nicolas
Publicado: (2019)

Thymic tumours and their special features
por: Basse, Clémence, et al.
Publicado: (2021)

Current perspectives on the optimal management of infantile hemangioma
por: Grzesik, Peter, et al.
Publicado: (2017)

Optimal management of genital herpes: current perspectives
por: Sauerbrei, Andreas
Publicado: (2016)

Optimal Management of Acromioclavicular Dislocation: Current Perspectives
por: Nolte, Philip C, et al.
Publicado: (2020)

Optimal management of symptomatic os acromiale: current perspectives
por: Spiegl, Ulrich J, et al.
Publicado: (2018)

Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
por: Mahé, Emmanuel
Publicado: (2020)

Clinical TNM staging of thymic epithelial malignancies
por: Ackman, Jeanne B.
Publicado: (2019)

Airway complications after lung transplantation: benefit of a conservative bronchoscopy strategy
por: Patoir, Arnaud, et al.
Publicado: (2020)

Thymic tumors: impact of the TNM for medical oncologists: extended abstract
por: Girard, Nicolas
Publicado: (2022)

Current Treatment Approaches for Thymic Epithelial Tumors
por: Tartarone, Alfredo, et al.
Publicado: (2023)

Optimal management of breast cancer in the elderly patient: current perspectives
por: Le Saux, Olivia, et al.
Publicado: (2015)

Optimal management of posterior cruciate ligament injuries: current perspectives
por: Shelbourne, K Donald, et al.
Publicado: (2017)

Optimal management of multiple sclerosis during pregnancy: current perspectives
por: Borisow, Nadja, et al.
Publicado: (2014)

Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives
por: Leow, Jeffrey J, et al.
Publicado: (2020)

Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma
por: Kitadai, Rui, et al.
Publicado: (2021)

Narrative review of immunotherapy in thymic malignancies
por: Benitez, Jose Carlos, et al.
Publicado: (2021)

Indolent stage IVA thymic malignancies managed with multimodality treatments
por: Hamaji, Masatsugu
Publicado: (2020)

Current use of extracorporeal life support in airway surgery: a narrative review
por: Slama, Alexis, et al.
Publicado: (2023)

Optimal management of common acquired melanocytic nevi (moles): current perspectives
por: Sardana, Kabir, et al.
Publicado: (2014)

Optimal Management of Dysphagia in Patients with Inoperable Esophageal Cancer: Current Perspectives
por: Mohapatra, Sonmoon, et al.
Publicado: (2022)

The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions
por: Berardi, Rossana, et al.
Publicado: (2020)

Determining extent of invasion and follow-up of thymic epithelial malignancies
por: Benveniste, Marcelo F., et al.
Publicado: (2019)

The role of induction therapy for thymic malignancies: a narrative review
por: Patel, Deven C., et al.
Publicado: (2020)

Autogenous pericardial angioplasty for thymic malignancies: a narrative review
por: Gao, Hui-Jiang, et al.
Publicado: (2021)

Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives
por: Pecher, Ann-Christin, et al.
Publicado: (2022)

Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives
por: Ao, Yong-Qiang, et al.
Publicado: (2023)

Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies
por: Gomez, Daniel R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kar3sd98bbf64osfn9g9olt3q9